Experimental Treatment of Ebola Virus Disease with Brincidofovir.

Experimental Treatment of Ebola Virus Disease with Brincidofovir.

<h4>Background</h4>The nucleotide analogue brincidofovir was developed to prevent and treat infections caused by double-stranded DNA viruses. Based on in vitro data suggesting an antiviral effect against Ebola virus, brincidofovir was included in the World Health Organisation list of age...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Jake Dunning, Stephen B Kennedy, Annick Antierens, John Whitehead, Iza Ciglenecki, Gail Carson, Rupa Kanapathipillai, Lyndsey Castle, Rebecca Howell-Jones, Raul Pardinaz-Solis, Jennifer Grove, Janet Scott, Trudie Lang, Piero Olliaro, Peter W Horby, RAPIDE-BCV trial team
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Public Library of Science (PLoS) 2016-01-01
Saila:PLoS ONE
Sarrera elektronikoa:https://doi.org/10.1371/journal.pone.0162199

Internet

https://doi.org/10.1371/journal.pone.0162199

Antzeko izenburuak